How were (ENZY)'s earnings last quarter?

(ENZY) (NASDAQ:ENZY) announced its earnings results on Wednesday, May, 17th. The biotechnology company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.06 by $0.03. The biotechnology company earned $12 million during the quarter, compared to the consensus estimate of $14.23 million. The business's revenue was down 14.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.09 EPS.

What other stocks do shareholders of (ENZY) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (ENZY) investors own include Caesarstone (CSTE) , Laredo Petroleum (LPI) , Allena Pharmaceuticals (ALNA) , Baidu (BIDU) , Camtek (CAMT) , Telaria (TLRA) , Arbutus Biopharma (ABUS) , AcelRx Pharmaceuticals (ACRX) , Ampliphi Biosciences (APHB) and Aquinox Pharmaceuticals (AQXP) .

NASDAQ:ENZY

(ENZY) (ENZY) Stock Price, News & Analysis

→ A.I. “Perfect Storm” Could Send THESE Stocks Sky High (From InvestorPlace) (Ad)

Free ENZY Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $11.85
▼
$11.85
50-Day Range: N/A
52-Week Range: $6.30
▼
$12.35

Volume: N/A
Average Volume: 120,557 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get (ENZY) alerts:

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

About (ENZY) Stock (NASDAQ:ENZY)

Enzymotec Ltd. is a nutritional ingredients and medical foods company. The Company's technologies, research expertise and clinical validation process enables it to develop solutions across a range of products. The Company operates in two segments: Nutrition segment and VAYA Pharma segment. Both of the Company's segments offer a range of products that leverage its lipid-related offerings. Its product suite addresses the entire human life-cycle, from infancy to old age, and comprises ingredients in products ranging from infant formula to nutritional supplements, as well as branded medical foods, sold only under a doctor's supervision. It markets its product portfolio to established global consumer companies and physicians and target large and growing consumer health and wellness markets. The Company's clinically-validated products include bio-functional lipid-based compounds designed to address dietary needs, medical disorders and common diseases.

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

ENZY Stock News Headlines

March 27, 2024 | finance.yahoo.com

Notice of Annual General Meeting 2024 in Enzymatica AB (publ)

March 13, 2024 | msn.com

Enzymatica wins CE-certification for nasal spray ColdZyme

April 16, 2024 | InvestorPlace (Ad)

A.I. “Perfect Storm” Could Send THESE Stocks Sky High

A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.

March 4, 2024 | msn.com

32 top US cities to have a cat

February 12, 2024 | msn.com

Novo Nordisk’s parent eyes $7B annual investments by 2030: FT

January 10, 2024 | msn.com

Co, gdzie, kiedy? Wydarzenia kulturalne i imprezy w Słupsku na ten tydzień

January 2, 2024 | msn.com

Earthquake Jolts Japan, No Indonesian Citizens Become Victims

December 18, 2023 | msn.com

'Hello Ghost' | Air date, plot, cast and is the Netflix movie worth watching

April 16, 2024 | InvestorPlace (Ad)

A.I. “Perfect Storm” Could Send THESE Stocks Sky High

A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.

November 29, 2023 | afr.com

Court blocks telehealth consultations for euthanasia

October 27, 2023 | yahoo.com

Hello Ghost: Where to Watch & Stream Online

October 25, 2023 | theglobeandmail.com

MyProtein Discount Codes October 2023

September 25, 2023 | finance.yahoo.com

Global Bromelain Market is Anticipated to Reach US$ 1.15 Billion by 2031, Registering a 4.5% CAGR: TMR Report

August 4, 2023 | msn.com

2 Men Allegedly Stole Roughly $9 Million in Jewelry, Cash from Russian Family at Barcelona Airport

August 4, 2023 | msn.com

Tinder will soon let AI pick your dating profile photos for you

July 26, 2023 | msn.com

Trump records video encouraging Republicans to vote early

May 25, 2023 | msn.com

How To Nail The Bare Skin Movement

May 1, 2023 | msn.com

59-year-old man charged in December cutting death of one man, wounding of another

April 5, 2023 | finanznachrichten.de

Enzymatica AB: Enzymatica publishes annual report for 2022

March 31, 2023 | finance.yahoo.com

Notice of Annual General Meeting 2023 in Enzymatica AB (publ)

March 29, 2023 | msn.com

Lyceum Lady Pirates, wagi kontra sa Perpetual Lady Altas sa NCAA 98 Women's Volleyball Tournament Semifinals | UB

March 15, 2023 | msn.com

15-year-old reported missing in Shelby County

March 5, 2023 | msn.com

Cops arrested over robbery, stolen police gun recovered from slain suspect

March 5, 2023 | msn.com

Apple iPhone 14, 14 Plus might soon come in this fresh and vibrant colour option

January 18, 2023 | reuters.com

ENZY.ST - | Stock Price & Latest News | Reuters

January 14, 2023 | msn.com

Trend-Spirituose: Was Sie schon immer über Gin wissen wollten

January 12, 2023 | marketwatch.com

Bromelain & Papain Market 2023 : Production Capacity, Restring Drivers, Size and Landscape Outlook 2028

See More Headlines

Receive ENZY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ENZY) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 5/17/2017
Today: 4/15/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:ENZY
CUSIP: N/A
CIK: 1578809
Web: www.enzymotec.com
Phone: +972-7-47177177
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Steve Dubin (Age 60)
Independent Chairman of the Board
Erez Israeli (Age 48)
President, Chief Executive Officer
Yoav Doppelt (Age 48)
Independent Vice Chairman of the Board
Dror Israel (Age 46)
Chief Financial Officer, Vice President
Yoav Kahane (Age 42)
Chairman of Advanced Lipids AB
Yoni Twito (Age 47)
Chief Operating Officer
Naama Zamir (Age 43)
Vice President - Human Resources and Information Systems
Gai Ben-Dror (Age 45)
Vice President - Process Development
Tzafra Cohen (Age 47)
Vice President - Research & Development
Tamar D. Howson (Age 68)
Director

ENZY Stock Analysis - Frequently Asked Questions

How were (ENZY)'s earnings last quarter?: (ENZY) (NASDAQ:ENZY) announced its earnings results on Wednesday, May, 17th. The biotechnology company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.06 by $0.03. The biotechnology company earned $12 million during the quarter, compared to the consensus estimate of $14.23 million. The business's revenue was down 14.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.09 EPS.
What other stocks do shareholders of (ENZY) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other (ENZY) investors own include Caesarstone (CSTE), Laredo Petroleum (LPI), Allena Pharmaceuticals (ALNA), Baidu (BIDU), Camtek (CAMT), Telaria (TLRA), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Ampliphi Biosciences (APHB) and Aquinox Pharmaceuticals (AQXP).

This page (NASDAQ:ENZY) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

(ENZY) (ENZY) Stock Price, News & Analysis

About (ENZY) Stock (NASDAQ:ENZY)

ENZY Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

ENZY Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info